Capital Flow Monitor · Sponsors · CIK 2096530
Par Health, Inc.
675 James S. McDonnell Blvd., St. Louis, MO, 63042 · 314-654-2000
Pharmaceuticals · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$763.0M
Sold
$763.0M
% sold
100.0%
Investors
234
Min investment
$0
Exemption
506(c)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-25 | D ·current | 506(c) | $763.0M | $763.0M | 100.0% | 234 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Stephen Welch — Executive Officer / Director, St. Louis, MO
- Jack Boyle — Executive Officer, St. Louis, MO
- Andrew Gonce — Executive Officer, St. Louis, MO
- Kass Harrold — Executive Officer, St. Louis, MO
- Jake Longenecker — Executive Officer, St. Louis, MO
- Matthew Maletta — Executive Officer, St. Louis, MO
- Mick McGuinness — Executive Officer, St. Louis, MO
- Teresa Sanzottera — Executive Officer, St. Louis, MO
- Scott Sims — Executive Officer, St. Louis, MO
- Jeffrey Wiegers — Executive Officer, St. Louis, MO
- Michael Heffernan — Director, St. Louis, MO
- Joshua Murray — Director, St. Louis, MO
- Matthew Stober — Director, St. Louis, MO
- Jonathan Zinman — Director, St. Louis, MO
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.